Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) EPS (Weighted Average and Diluted) Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -19.74%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.20%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.88%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 100.00%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 8.20%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 88.89%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.89%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 47.37%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn 101.90%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 101.90%
Sep 30, 2025 125.00%
Jun 30, 2025 166.67%
Mar 31, 2025 101.35%
Dec 31, 2024 33.33%
Sep 30, 2024 -157.14%
Jun 30, 2024 -50.00%
Mar 31, 2024 -50.00%
Dec 31, 2023 -50.00%
Sep 30, 2023 333.33%
Jun 30, 2023 0.00%
Mar 31, 2023 33.33%
Dec 31, 2022 33.33%
Sep 30, 2022 -50.00%
Jun 30, 2022 -100.00%
Mar 31, 2022 -8,305.06%
Dec 31, 2021 -113.04%
Sep 30, 2021 80.00%
Jun 30, 2021 94.74%
Mar 31, 2021 99.81%
Dec 31, 2020 276.92%
Sep 30, 2020 28.57%
Jun 30, 2020 -26.67%
Mar 31, 2020 9.52%
Dec 31, 2019 97.28%
Sep 30, 2019 41.67%
Jun 30, 2019 60.53%
Mar 31, 2019 70.00%
Dec 31, 2018 74.60%
Sep 30, 2018 95.73%
Jun 30, 2018 94.09%
Mar 31, 2018 81.91%
Dec 31, 2017 -9.29%
Sep 30, 2017 -1,305.00%
Jun 30, 2017 -1,637.84%
Mar 31, 2017 -723.40%
Dec 31, 2016 -1,279.45%
Sep 30, 2016 37.50%
Jun 30, 2016 9.76%
Mar 31, 2016 24.19%
Dec 31, 2015 392.00%
Sep 30, 2015 -236.84%
Jun 30, 2015 -17.14%
Mar 31, 2015 19.48%
Dec 31, 2014 80.92%
Sep 30, 2014 -137.50%
Jun 30, 2014 36.36%
Mar 31, 2014 -1,825.00%
Dec 31, 2013 -2,281.82%
Sep 30, 2013 -33.33%
Jun 30, 2013 -2,850.00%
Mar 31, 2013 -33.33%
Dec 31, 2012 0.00%
Sep 30, 2012 25.00%
Jun 30, 2012 300.00%
Mar 31, 2012 -127.27%
Dec 31, 2011 42.11%
Sep 30, 2011 69.23%
Jun 30, 2011 85.71%